Esketamine Single Patient Request
Latest Information Update: 11 Feb 2020
Price :
$35 *
At a glance
- Drugs Esketamine (Primary)
- Indications Depression; Major depressive disorder
- Focus Expanded access; Therapeutic Use
- Sponsors Janssen Research & Development
- 25 Mar 2019 Status changed from recruiting to completed.
- 11 Feb 2019 New trial record